Community/Retail

Evolocumab cut low-density lipoprotein cholesterol levels by 60%, on average, in patients with heterozygous familial hypercholesterolemia

Deciding whether to pursue a PGY-1 Pharmacy Residency is a big task. Why not ask someone who's already there?

Tabalumab failed to establish efficacy compared with current standard of care therapy in 2 pivotal late-stage trials.

Although energy drinks may improve athletic performance, they may also increase the risk for insomnia and nervousness.

By generating thousands of tweets using the hashtag #Pharmacist, pharmacy organizations and pharmacists around the world have made their impact on patients and the health care industry known to the global Twitter community.

Study shows administration of high-dose vitamin D to intensive care unit patients did not significantly reduce length of hospital stay or hospital mortality.

Four children who recently died have tested positive for enterovirus D68, though it is not yet clear what role, if any, the virus played in their deaths.

Tests that may help health care professionals diagnose influenza more quickly and accurately have received support from the US Department of Health and Human Services.

Twenty-five years ago, I was an incoming freshman at the Philadelphia College of Pharmacy and Science.

Is there such a phenomenon as corticosteroid-induced anaphylaxis?

Pharmacists and pharmacy organizations around the world are taking to Twitter to spread the word about their impact on patients, communities, and the health care industry.

Controversy surrounding early goal-directed therapy in septic shock has heightened with the publication of the ARISE trial.

Officials stress that the strength of the US health care system will contain the virus.

New guidelines from the American Thyroid Association recommend that levothyroxine should remain the standard of care for treating hypothyroidism.

Pharmacist-led drug use evaluation programs improve osteoporosis management in general practice.

The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.

In celebration of American Pharmacists Month, pharmacists are encouraged to spread the word about their work throughout the month of October.